Home▸Sexual Health — Libido & Premature Ejaculation▸Flibanserin & Bremelanotide Mechanism Simulator

❤️ Flibanserin & Bremelanotide Mechanism Simulator

The simulator models the action of flibanserin (modulation of serotonin receptors in the brain) and bremelanotide (agonist of melanocortin receptors) in treating low libido in women, focusing on their specific mechanisms of action.

Sexual Health — Libido & Premature Ejaculation2DModerate60 FPS
flibanserin-bremelanotide-mechanism-simulator ↗ Open standalone

Low Sexual Desire — Starting Point

Baseline circuit activity before pharmacologic intervention begins.

  • ~10%: HSDD prevalence (placeholder estimate)
  • Elevated: Serotonin tone (placeholder baseline)
  • Low: Melanocortin tone (placeholder baseline)
  • Low: Desire response (placeholder baseline)

Baseline neurocircuitry

Placeholder: excitatory and inhibitory desire pathways sit imbalanced.

Flibanserin — Daily Serotonin Modulator

Flibanserin is taken daily to rebalance serotonin receptor signaling.

  • 100 mg/day: Dosing (placeholder regimen)
  • Weeks: Onset (placeholder timeline)
  • 5-HT1A/2A: Target (placeholder receptors)
  • Multifunctional: Class (placeholder label)

Daily oral mechanism

Placeholder: drug crosses blood-brain barrier and binds serotonin receptors.

Serotonin Receptor Modulation Over Time

Gradual receptor changes accumulate with continued daily dosing.

  • Agonized: 5-HT1A (placeholder direction)
  • Antagonized: 5-HT2A (placeholder direction)
  • ~4 wks: Full effect (placeholder timeline)
  • On stop: Reversal (placeholder note)

Cumulative modulation

Placeholder: receptor tone shifts slowly across the dosing period.

Bremelanotide — On-Demand Melanocortin Agonist

Bremelanotide is self-injected shortly before anticipated activity.

  • On-demand: Dosing (placeholder regimen)
  • Subcutaneous: Route (placeholder route)
  • MC4R: Target (placeholder receptor)
  • ~45 min: Onset (placeholder timeline)

Rapid receptor engagement

Placeholder: injected drug quickly reaches hypothalamic melanocortin receptors.

Melanocortin Receptor Activation Spike

MC4R activation rises sharply then fades after the dose wears off.

  • Sharp spike: Peak activation (placeholder pattern)
  • Hours: Duration (placeholder timeline)
  • Nausea/flushing: Side effects (placeholder note)
  • 8/month: Frequency cap (placeholder limit)

Peak response window

Placeholder: desire response peaks then declines as drug clears.

⚙ Under the hood

The simulator models the action of flibanserin (modulation of serotonin receptors in the brain) and bremelanotide (agonist of melanocortin receptors) in treating low libido in women, focusing on their specific mechanisms of action.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)